Back to top

Image: Bigstock

Ventas (VTR) Reports Q3 Earnings: What Key Metrics Have to Say

Read MoreHide Full Article

For the quarter ended September 2026, Ventas (VTR - Free Report) reported revenue of $1.83 billion, up 23% over the same period last year. EPS came in at $0.99, compared to $0.14 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.76 billion, representing a surprise of +3.99%. The company delivered an EPS surprise of +1.02%, with the consensus EPS estimate being $0.98.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Ventas performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Revenues- Interest and other income: $1.96 million compared to the $1.89 million average estimate based on two analysts. The reported number represents a change of -53.1% year over year.
  • Revenues- Rental income- Outpatient medical & research portfolio: $233.24 million versus the two-analyst average estimate of $229.46 million. The reported number represents a year-over-year change of +3.1%.
  • Revenues- Income from loans and investments: $12.17 million compared to the $8.16 million average estimate based on two analysts. The reported number represents a change of +120.2% year over year.
  • Revenues- Resident fees and services: $1.45 billion versus $1.39 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +33.3% change.
  • NOI- Senior housing operating portfolio (SHOP): $429.97 million versus the two-analyst average estimate of $406.44 million.
  • Net Earnings Per Share (Diluted): $0.13 versus the two-analyst average estimate of $0.14.
  • NOI- Triple-net leased properties (NNN): $126.28 million compared to the $122.26 million average estimate based on two analysts.
  • NOI- Outpatient medical & research portfolio (OM&R): $153.43 million versus the two-analyst average estimate of $152.02 million.

View all Key Company Metrics for Ventas here>>>

Shares of Ventas have returned +0.4% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Published in